Page 4 - Torrent Pharmaceuticals

Pharmacy consolidation may disrupt domestic drug market: Credit Suisse

The report says if chemists are allowed to replace doctor's prescription with a generic drug, firms with high exposure to chronic therapeutic drugs will be impacted more

Robust performance of domestic biz to help Torrent Pharma outperform peers

Chronic-heavy portfolio, pharma market recovery boost shares

Torrent Pharma leaps 10%, nears 52-wk high as Q1 net profit jumps 49% YoY

In terms of markets, while its India revenues grew marginally by 2% on a year-on-year (YoY) basis to Rs 925 crore, up from Rs 907 crore in Q1 of FY20, its US revenues fell by 1% to Rs 373 crore

Trading ideas by Religare Broking: Buy IGL, Torrent Pharmaceuticals

IGL has tested the major support zone of the long-term moving average (200 EMA) on the daily chart of late

India growth crucial for Torrent Pharma's health amid steep fall in volume

The country accounts for 44% of overall revenues

Torrent Pharma says promoters haven't pledged equity, NSE action not needed

Torrent said a pledge of shares is a security interest in favour of lenders and can be enforced by sale of such shares in event of default

Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crore

The approval of the shareholders was sought by way of special resolution through a postal ballot

Derivatives strategy on Torrent Pharmaceuticals by HDFC Securities

Derivative strategy on Pidilite Industries by Vinay Rajani -Technical and Derivatives analyst, HDFC Securities.

Torrent Pharma Q3 result: PBT rises 16% to Rs 319 crore, revenue declines

US business down by 22% in third quarter, India revenues grow by 5%

Torrent Pharma rebounds 9% from day's low on heavy volumes

The US Food and Drug Administration (USFDA) has issued a warning letter to Torrent Pharma's Indrad (Gujarat) API and formulations facility.

Torrent Pharmaceuticals manages to improve Unichem's FY19 profits

Losar comprised almost 20% of the acquired portfolio of Unichem

Strong domestic business shot in the arm for Torrent Pharma stock

Turnaround of acquired Unichem biz, improving margins, and large brands to aid earnings

Glenmark, Torrent Pharma sign agreement to co-market diabetes drug in India

Glenmark launched Remogliflozin, indicated in the treatment of Type 2 Diabetes Mellitus in adults under the brand names Remo and Remozen

Overseas growth gets critical for Torrent Pharma as Unichem drags India biz

While it continues to work on integrating Unichem in its specialty model, Torrent Pharma will focus on overseas geographies like US, Brazil and Germany

How Torrent Pharma is integrating Unichem to boost its domestic business

The Ahmedabad-based pharma company plans to launch its first product from Bio-Pharm stable this quarter in the US; Unichem MR attrition rate has halved in the hope of a turnaround

Torrent Pharma puts US business on fast track: Acquires Bio-Pharm Inc

Acquisition of BPI helps the company to enter a limited competition category

Torrent's Unichem deal to add to its earnings after 3 years

For Unichem investors, larger gains will accrue if international business grows fast

Torrent Pharma to pay Rs 3,600 crore for Unichem's branded business

At Rs 3,600 crore, Torrent is paying 4.2 times its revenue for this acquisition

Torrent to buy Unichem's domestic biz for Rs 3,500 cr; announcement today

What makes Unichem lucrative to potential buyers is that only 10-12 per cent of its domestic drug portfolio comes under the National List of Essential Medicines

Torrent Pharma turns around Brazil business with 25% revenue jump

In 2015-16, the company's revenue in Brazil had declined 17% to Rs 506 crore